Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human |
Host species | Goat |
Applications | ELISA,WB-Ce |
Brand: | Abnova |
Reference: | PAB6950 |
Product name: | CDKN2A polyclonal antibody |
Product description: | Goat polyclonal antibody raised against synthetic peptide of CDKN2A. |
Gene id: | 1029 |
Gene name: | CDKN2A |
Gene alias: | ARF|CDK4I|CDKN2|CMM2|INK4|INK4a|MLM|MTS1|TP16|p14|p14ARF|p16|p16INK4|p16INK4a|p19 |
Gene description: | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
Immunogen: | A synthetic peptide corresponding to human CDKN2A. |
Immunogen sequence/protein sequence: | C-HARIDAAEGPSDIPD |
Protein accession: | NP_000068.1 |
Form: | Liquid |
Concentration: | 0.5 mg/mL |
Recommend dilutions: | ELISA (1:32000) Western Blot (0.1-1 ug/mL) The optimal working dilution should be determined by the end user. |
Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Goat |
Antigen species / target species: | Human |
Specificity: | This antibody is expected to recognize isoform 1 only (NP_000068.1). |
Reactivity: | Human |
Application image: | ![]() |
Application image note: | CDKN2A polyclonal antibody (Cat # PAB6950) (1 ug/mL) staining of HeLa Lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
Applications: | ELISA,WB-Ce |
Shipping condition: | Dry Ice |
Publications: | Alterations of cell cycle regulators in gliomatosis cerebri.Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Deimling A, Stoltenburg-Didinge G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K. J Neurooncol. 2005 Apr;72(2):115-22. |